Cytokinetics, Incorporated

NASDAQ:CYTK

55.94 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Operating Activities:
Net Income -526.244-388.955-215.314-127.29-121.692-106.289-127.7916.453-37.501-14.646-33.717-40.37-47.86-49.28724.544-56.374-48.894-57.115-42.252-37.198-32.685-23.08
Depreciation & Amortization 11.8925.8142.2761.8311.2931.2391.920.7410.5890.490.4330.5911.2971.92.0212.4562.8292.9273.0623.2763.1812.849
Deferred Income Tax 4.61902.844-0.57300-0.067-0.018-0.021-3.336-3.676-0.00247.86349.294-0.04-5.603-4.63-4.651-1.427-1.87600
Stock Based Compensation 72.06547.85326.83217.6210.7599.7619.0287.1464.5673.333.5973.7833.0694.0174.9065.6064.6434.6431.4271.87600
Change In Working Capital 3.089-24.7048.45689.117-0.336-22.9360.48712.12637.246-34.01122.0482.616-2.298-1.476-24.715-13.6337.2792.184-1.898-2.092-2.218-1.904
Accounts Receivables -1.13656.672-47.3990.743-2.932-1.119-1.088-0.01246.634-46.64100.010.0320.1340.041-0.145-41.515-41.515-0.5440.07400
Inventory 0001.484-5.3524.908-1.3958.2382.599-2.5910-67.544-49.04-67.248-1.349-1.3783.2412.347-68.763-100.3070-0.342
Accounts Payables -3.4834.5241.055-0.114.396-1.491.4571.6980.755-2.1781.5060.8280.162-0.5360.334-0.0060.8520.852-0.1910.11300
Other Working Capital 7.708-85.954.8873.552-25.2351.5132.202-12.74217.39920.54269.32246.54866.174-23.741-12.109-5.29940.567.698.028-2.218-1.562
Other Non Cash Items 20.24660.47632.38428.23819.06917.0114.6630.5340.0033.333.597-0.056-47.666-49.2781.76.2175.7684.8421.6041.9821.209-0.168
Operating Cash Flow -414.333-299.516-142.5228.943-90.907-101.215-101.75936.9824.883-44.843-7.718-33.438-45.595-44.838.416-61.328-3.005-47.17-39.484-34.032-30.513-22.303
Investing Activities:
Investments In Property Plant And Equipment -1.416-11.335-48.872-11.052-2.619-0.889-2.877-1.596-0.562-1.104-0.542-0.125-0.443-0.493-0.55-0.658-2.563-5.37-1.465-1.4-3.051-6.57
Acquisitions Net -240.669250.79998.905185.46372.0880.01400.0330.001000.0020.0030.0140.074000.0060.02000
Purchases Of Investments -635.211-855.393-525.042-435.825-277.883-240.224-240.413-145.158-115.566-107.043-79.434-92.788-48.025-109.86-132.205-24.462-51.7-143.046-89.326-189.451-54.9710
Sales Maturities Of Investments 875.88604.594426.137250.362205.795246.232177.46294.645132.19104.09878.44463.973.174143.6978.09512.60798.729135.527123.995124.2336.99536.768
Other Investing Activites 240.669-250.799-98.905-185.463-72.0880.014-62.9510.0330.001-2.9450.0130.1960.5920.8861.1062.5470.996-0.7991.2681.1155.907-7.62
Investing Cash Flow 239.253-262.134-147.777-196.515-74.7075.133-65.828-52.07616.063-4.049-1.519-28.81525.30134.237-53.48-9.96645.462-13.68234.492-65.506-15.1222.578
Financing Activities:
Debt Repayment -0.858-188.92500-122.184-9.898-1.261-14.996-14.8900-0.152-0.833-11.817-4.2790000000
Common Stock Issued 182.69217.543312.049225.10836.2143.234119.7841.8968.67348.97114.48843.34110.6960.42513.7740.59936.86685.2521.054101.93140.1780.068
Common Stock Repurchased -10.51717.543-4.449-2.255000000000000-0.002-0.002-0.025-0.020-0.002
Dividends Paid 0000000000000000000000
Other Financing Activities 232.692670.00512.3811.271245.76113.132106.13516.89215.242-0.02214.48815.13811.7513.93819.311-4.05-2.1441.4744.4170.410.0584.803
Financing Cash Flow 221.317516.166319.98234.124159.79113.132225.91916.89223.91548.94914.48858.32721.6132.54628.806-3.45134.7286.7245.446102.32140.2364.869
Other Information:
Effect Of Forex Changes On Cash -0.02000000000000000000000
Net Change In Cash 47.817-45.48429.68146.552-5.823-82.9558.3321.79844.8610.0575.251-3.9261.319-8.047-16.258-74.74577.17725.8720.4542.783-5.3975.144
Cash At End Of Period 113.39967.182112.66682.98536.43342.256125.20666.87465.07620.21520.15814.90718.83317.51425.56141.819116.56439.38713.51513.06110.99116.388